chr6-52237020-G-C
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_052872.4(IL17F):c.403C>G(p.Gln135Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000248 in 1,614,092 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q135R) has been classified as Uncertain significance.
Frequency
Consequence
NM_052872.4 missense
Scores
Clinical Significance
Conservation
Publications
- chronic mucocutaneous candidiasisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- candidiasis, familial, 6Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| IL17F | NM_052872.4 | c.403C>G | p.Gln135Glu | missense_variant | Exon 3 of 3 | ENST00000336123.5 | NP_443104.1 | |
| IL17F | XM_011514276.1 | c.403C>G | p.Gln135Glu | missense_variant | Exon 4 of 4 | XP_011512578.1 | ||
| LOC124901328 | XR_007059607.1 | n.-66G>C | upstream_gene_variant |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| IL17F | ENST00000336123.5 | c.403C>G | p.Gln135Glu | missense_variant | Exon 3 of 3 | 1 | NM_052872.4 | ENSP00000337432.4 | ||
| IL17F | ENST00000478427.1 | n.587C>G | non_coding_transcript_exon_variant | Exon 2 of 2 | 1 | |||||
| IL17F | ENST00000699946.1 | c.403C>G | p.Gln135Glu | missense_variant | Exon 4 of 4 | ENSP00000514702.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152228Hom.: 0 Cov.: 32 show subpopulations
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461864Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 727234 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152228Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74368 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Candidiasis, familial, 6 Uncertain:1
This sequence change replaces glutamine with glutamic acid at codon 135 of the IL17F protein (p.Gln135Glu). The glutamine residue is moderately conserved and there is a small physicochemical difference between glutamine and glutamic acid. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with IL17F-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The glutamic acid amino acid residue is found in multiple mammalian species, suggesting that this missense change does not adversely affect protein function. These predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at